A CRISPR interference platform for selective downregulation of gene expression in <i>Borrelia burgdorferi</i>
Constantin N. Takacs(Howard Hughes Medical Institute), Christine Jacobs‐Wagner(Howard Hughes Medical Institute), Zachary A. Kloos(Yale University), Patricia A. Rosa(National Institutes of Health), Jun Liu(Jinan University), Yunjie Chang(Hunan Institute of Technology), Irnov Irnov(Howard Hughes Medical Institute), Molly Scott(Yale University)
Cited by 4
Related Papers
Targeted Delivery of CRISPR/Cas9‐Mediated Cancer Gene Therapy via Liposome‐Templated Hydrogel Nanoparticles
|Advanced Functional Materials|2017|297
RodZ, a component of the bacterial core morphogenic apparatus
|Proceedings of the National Academy of Sciences|2009|173
Progression of Vascular Calcification and Clinical Outcomes in Patients Receiving Maintenance Dialysis
|JAMA Network Open|2023|116
Unphosphorylated STAT3 modulates alpha7 nicotinic receptor signaling and cytokine production in sepsis
|European Journal of Immunology|2010|114
The Serum Profile of Hypercytokinemia Factors Identified in H7N9-Infected Patients can Predict Fatal Outcomes
|Scientific Reports|2015|110